| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Pharmacology, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
Cyclosporine A, which has been the foremost immunosuppressive agent since the early 1980’s, significantly improves the success of organ transplantation. However, common complications of cyclosporine A therapy, such as severe renal tubulointerstitial fibrosis, limit the drug’s clinical use. Although the exact mechanisms driving cyclosporine A-induced tubulointerstitial fibrosis remain elusive, we hypothesized that epithelial-mesenchymal transition (EMT) may play a major role. We investigated this in vitro by treating human proximal tubular cells with cyclosporine A. Morphological changes were observed after cyclosporine A treatment, including cell elongation (with a large degree of detachment), cytoskeletal rearrangement, and junctional disruption. In addition, expression of the myofibroblast-specific marker 
-smooth muscle actin was detected in treated cells. These observations are consistent with events described during EMT. Using Affymetrix gene microarrays, we identified 128 genes that were differentially regulated in renal tubular cells after cyclosporine A treatment, including known profibrotic factors, oncogenes, and transcriptional regulators. Cyclosporine A induced a dose-dependent increase in transforming growth factor-ß secretion from proximal tubular cells. Subsequent functional studies revealed that protein kinase C-ß isoforms play a key role in cyclosporine A-induced effects. These findings provide novel insights into cyclosporine A-induced renal fibrosis and the molecular mechanisms underlying EMT, events that may be relevant in other disease states.
This article has been cited by other articles:
 |
|
 |
|
  M. J. Vitalone, P. J. O'Connell, E. Jimenez-Vera, A. Yuksel, M. Wavamunno, C. L.-S. Fung, J. R. Chapman, and B. J. Nankivell Epithelial-to-Mesenchymal Transition in Early Transplant Tubulointerstitial Damage J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1571 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Kattla, R. M. Carew, M. Heljic, C. Godson, and D. P. Brazil Protein kinase B/Akt activity is involved in renal TGF-{beta}1-driven epithelial-mesenchymal transition in vitro and in vivo Am J Physiol Renal Physiol, July 1, 2008; 295(1): F215 - F225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sebe, S.-K. Leivonen, A. Fintha, A. Masszi, L. Rosivall, V.-M. Kahari, and I. Mucsi Transforming growth factor-{beta}-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38{beta} mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1537 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Li, K. S. Hering-Smith, E. E. Simon, and V. Batuman Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells Nephrol. Dial. Transplant., March 1, 2008; 23(3): 860 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Jevnikar and R. B. Mannon Late Kidney Allograft Loss: What We Know about It, and What We Can Do about It Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(Supplement_2): S56 - S67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Feldman, B. Kiely, N. Martin, G. Ryan, T. McMorrow, and M. P. Ryan Role for TGF-beta in Cyclosporine-Induced Modulation of Renal Epithelial Barrier Function J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1662 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zhang, Z. Dong, and T. Yang Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1332 - F1342. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
